Clinical • Tumor mutational burden
|
TMB (Tumor Mutational Burden) • ABL1 (ABL proto-oncogene 1) • IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2) • FGFR1 (Fibroblast growth factor receptor 1) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • JAK2 (Janus kinase 2) • ASXL1 (ASXL Transcriptional Regulator 1) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • ETV6 (ETS Variant Transcription Factor 6) • CRLF2 (Cytokine Receptor Like Factor 2) • IKZF1 (IKAROS Family Zinc Finger 1) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • PAX5 (Paired Box 5) • CEBPA (CCAAT Enhancer Binding Protein Alpha) • P2RY8 (P2Y Receptor Family Member 8) • ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase)
|
IDH2 mutation • ASXL1 mutation • IDH2 R140Q
|
PDGFRB FISH Assay